A5041982092- Lymphoma Diagnosis and Treatment
- Neutropenia and Cancer Infections
- Chemotherapy-induced cardiotoxicity and mitigation
- Chronic Myeloid Leukemia Treatments
- Inflammatory Biomarkers in Disease Prognosis
- Chronic Lymphocytic Leukemia Research
- Colorectal Cancer Treatments and Studies
- Adrenal and Paraganglionic Tumors
- Iron Metabolism and Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Erythropoietin and Anemia Treatment
- Bacillus and Francisella bacterial research
- Cancer-related cognitive impairment studies
- Dialysis and Renal Disease Management
- Viral-associated cancers and disorders
- Cardiac Imaging and Diagnostics
- Hepatitis B Virus Studies
- Cancer, Hypoxia, and Metabolism
- Hematological disorders and diagnostics
- Salivary Gland Tumors Diagnosis and Treatment
- Glycogen Storage Diseases and Myoclonus
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Clostridium difficile and Clostridium perfringens research
- Folate and B Vitamins Research
Hacettepe University
2023-2025
The objective of this study is to evaluate the correlation between survival outcomes and modified cachexia index (mCXI) in patients with metastatic breast cancer who have been treated cyclin-dependent kinase (CDK) 4/6 inhibitors. This was conducted on received CDK inhibitors (either Palbociclib or Ribociclib) January 2020 November 2024. 240 were included. A total 236 (98.3%) female. Median age 57 (IQR: 48-66 years). median follow-up period from initiation last control 20 months. One hundred...
Background: Several studies have suggested that the serum albumin-creatinine ratio (sACR) is a useful marker for early risk stratification of patients with cardiomyocyte injury. This study aims to evaluate relationship between sACR and anthracycline-related cardiotoxicity. Methods: included who had received anthracycline-based chemotherapy 2014 2023 undergone baseline follow-up echocardiography after treatment. The level was calculated using albumin creatinine values obtained before...
Abstract Background The objective of this study is to assess the correlation between survival outcomes and sACR in patients who are treated with immune checkpoint inhibitors (ICIs). Methods This was conducted on individuals were administered ICI at least 3 doses from 2018 2023. Serum-albumin creatinine ratio (sACR) measured using serum albumin values before immunotherapy. Based median level, divided into two groups: sACR-High sACR-Low. relationship progression-free (PFS) overall (OS),...
<title>Abstract</title> Intravenous (IV) iron is frequently used to treat deficiency, even though oral therapy recommended as a first-line treatment in most cases. IV provides various benefits but also has drawbacks, including high costs, potential allergic reactions, and the need for hospitalization. In this study, we assessed patient disease-related factors of re-evaluated appropriateness using an algorithm created by reviewing current guidelines literature. A retrospective single-center...
Bacillus thermoamylovorans is a species of bacillus that causes structural defects in milk by contaminating with its heat-resistant spores. We report case diffuse pustular rash on the extremities and bacteremia blood culture after erythrocyte suspension replacement. On admission, his acute phase reactants were elevated he had generalized rash. After appropriate antibiotherapy, lesions regressed almost completely. There no transfusion-associated literature. This presented to contribute...
Primary adrenal lymphoma (PAL) is an extremely rare among the causes of incidentaloma. Most were diagnosed with insufficiency and B symptoms (unexplained weight loss, night sweats, fever). This article presented a 57-year-old woman who was investigated for bilateral masses found incidentally on computed tomography (CT). Physical examination laboratory tests revealed no evidence or symptoms. Only 24-hour urinary metanephrine normetanephrine excretion increased. Tumour F-18 fluorodeoxyglucose...
Ponatinib is a third-generation tyrosine kinase inhibitor with potent efficacy in the treatment of acute and chronic leukemia. Despite having an effective sustained activity all BCR-ABL1 mutations, it may cause cardiovascular adverse effects. Here we report 56-year-old male patient Chronic myeloid leukemia no prior cardiac disorder who developed heart failure under ponatinib treatment. Guideline-recommended medical for was initiated. Coronary angiography to exclude ischemic disease revealed...
To the Editor, Nilotinib, a second-generation tyrosine kinase inhibitor (TKI), is employed in treatment of chronic myeloid leukemia (CML) [1].However, previous studies have indicated an association between nilotinib and vascular adverse events, including peripheral arterial occlusive disease, cerebrovascular coronary artery disease [2,3].We report case significant bilateral carotid stenoses without any neurologic symptom and, at same time, left subclavian celiac atherosclerotic or...